|
GE Healthcare has released Vscan, a pocket-sized visualization tool developed to provide physicians with imaging capabilities at the point of care.
Benefits from EHR and e-prescribing investments come under very broad, diverse categories but are very individual and specific to the retrospective context of an investment, according to a study by the European Commission. There is no single correct strategy for implementing EHRs and e-prescribing systems, yet the results of the study give grounds for optimism in the success, value and deployment of interoperable EHR and e-prescribing systems after a few years.
Merge Healthcare and medical device and services for diagnostic imaging provider Medrad have revealed their plan to expand their European Union distribution agreement for CADstream.
The FDA has granted 510(k) marketing clearance to therapeutic ultrasound developer EDAP TMS for its Sonolith I-Sys device.
The FDA and the European Medicines Agency (EMEA) have launched a bilateral Good Clinical Practices initiative, designed to ensure that clinical trials submitted for drug marketing applications in the United States and Europe are conducted uniformly, appropriately and ethically.
European MRI manufacturers may get a permanent reprieve if the European Commission amends a directive that would restrict the use of MRIs in the European Union (EU).
U.S. device manufacturers hope an "action program" adopted by the Japanese government in December, and tied to increased industry user fees, will significantly speed device approval times in the Japanese market.
PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions, has reported that it is prepared to increase production and availability of 18F Sodium Fluoride (NaF) to replace Technetium MDP bone scans, in light of recent shortage of molybdenum, which has caused a temporary shortage of 99mTc-labeled radiopharmaceuticals.
The German government revealed plans to begin issuing electronic health cards by January 2006 to customers of every health insurer in the country, a move that is anticipated to save the country up to $1.7 billion in three years.
|
The FDA has approved Stereotaxis’ Celsius RMT ThermoCool for use with the company’s magnetic navigation system for the treatment of type 1 atrial flutter.
The European Union has granted heart disease monitoring systems developer VentriPoint Diagnostics CE mark approval for its VentriPoint Medical System (VMS).
The European Union funded-HYPERImage research project has created hybrid PET/MR technology, according to a presentation at the IEEE Nuclear Science Symposium and Medical Imaging Conference, this week in Orlando, Fla.
A public survey conducted in Europe found that the vast majority of people overestimate the life-saving benefits of breast and prostate cancer screening, according to a new study published online Aug. 12 in the Journal of the National Cancer Institute.
Covidien Limited, a medical device and pharmaceuticals manufacturer formerly based in Hamilton, Bermuda, now has its headquarters in Dublin, Ireland.
Covidien Limited, which is chartered in Hamilton, Bermuda, has reported that its board voted to move its incorporation to Ireland next year, as part of a reorganization that will create an Irish holding company, Covidien plc.
A European Union project aims to create an Ebay-style online market for radiology services.
The European Medicines Agency (EMEA), at the request from the European
Commission, has performed an analysis on the current shortage of
radiopharmaceuticals in the European Union to develop potential
solutions.
|